"covax-facility"

The Oxford-AstraZeneca doses from COVAX will be for the most vulnerable persons above 60 years of age group in the most high-risk areas impacted by COVID-19.

In 2021, the dashboard will provide an update on the status of procurement by the Unicef and other buyers participating in the COVAX Facility. I